Skip to main content

CCR Down Under

December 9th - 10th, 2025

The Edge, Federation Square, Melbourne

Presentations


Trial Results:  ADAPT Sepsis  |  VACiRISS  |  ALBICS AKI  |  SAHaRA  |  TRAUMOX2  |  RENOVATE  |  EVIDENCE  |  SCREEN

please note VACiRISS and EVIDENCE are presently unpublished

ADAPT Sepsis


Paul Dark (Manchester) delivers the results of the ADAPT‑Sepsis trial at Critical Care Reviews Down Under 2024 at The Edge, Melbourne. An independent editorial is provided by Marion Campbell (Aberdeen). The panelists are Michael Bailey (Melbourne), Naomi Hammond (Sydney), Sandra Peake (Adelaide), and Yaseen Arabi (Riyadh). The session is chaired by Kathy Rowan (London). The ADAPT‑Sepsis trial evaluated biomarker-guided antibiotic duration in hospitalised patients with suspected sepsis.

Interview with the Trialist

Unedited ADAPT Sepsis Trial Results Presentation


ALBICS AKI


Yahya Shehabi (Melbourne) and Mayu Balachandran (Melbourne) present the results of the ALBICS‑AKI trial at Critical Care Reviews Down Under 2024 at The Edge, Melbourne. An independent editorial is delivered by Tomoko Fujii (Tokyo). The panelists are Victoria Cornelius (London), Naomi Hammond (Melbourne), Rachel Parke (Auckland), and Bala Venkatesh (Brisbane). The session is chaired by Chris Seymour (Pittsburgh). The ALBICS‑AKI trial investigated whether postoperative 20% albumin reduces acute kidney injury in high‑risk cardiac surgery patients.

Interview with the Trialist

Unedited ALBICS AKI Trial Results Presentation


SAHARA Trial


Shane English (Ottawa) and Anthony Delaney (Ottawa) present the results of the SAHaRA trial at Critical Care Reviews Down Under 2024 at The Edge, Federation Square. An independent editorial is delivered by Jamie Cooper (Canberra). The panelists are Marion Campbell (Aberdeen), Celia Bradford (Sydney), Lisa Higgins (Melbourne), and Paul Young (Auckland). The session is chaired by Darren Taichman (Philadelphia). The SAHaRA trial examined liberal versus restrictive red blood cell transfusion strategies in patients with aneurysmal subarachnoid hemorrhage.

Interview with the Trialists

Unedited SAHaRA Trial Results Presentation


TRAUMOX2 Trial


Jacob Steinmetz (Copenhagen) presents the results of the TRAUMOX2 trial at Critical Care Reviews Down Under 2024 at The Edge, Federation Square. An independent editorial is delivered by Paul Young (Wellington). The panelists are Victoria Cornelius (London), Carol Hodgson (Melbourne), Brian Burns (Sydney), and John Myburgh (Sydney). The session is chaired by Kathy Rowan (London). The TRAUMOX2 trial investigated restrictive versus liberal oxygen strategies in trauma patients.

Interview with the Trialist

Unedited TRAUMOX2 Trial Results Presentation


RENOVATE Trial


Israel Maia (Sao Paulo) presents the results of the RENOVATE trial at Critical Care Reviews Down Under 2024 at The Edge, Melbourne. An independent editorial is delivered by Danny McAuley (Belfast). The panelists are Michael Bailey (Melbourne), Carol Hodgson (Melbourne), Sandra Peake (Adelaide), and Simon Finfer (Sydney). The session is chaired by Andrew Udy (Melbourne). The RENOVATE trial evaluated high-flow nasal cannula versus non-invasive ventilation in acute respiratory failure.

Interview with the Trialist

Unedited RENOVATE Trial Results Presentation


SCREEN Trial


Yaseen Arabi (Riyadh) presents the results of the SCREEN trial at Critical Care Reviews Down Under 2024 at The Edge, Federation Square. An independent editorial is delivered by Kathy Rowan (London). The panelists are Liz Ryan (Melbourne), Sarah Sasson (Sydney), Rinaldo Bellomo (Melbourne), and Manu Shankar-Hari (Edinburgh). The session is chaired by Lisa Higgins (Melbourne). The SCREEN trial assessed electronic early notification systems for sepsis detection in hospitalized ward patients.

Interview with the Trialist

Unedited SCREEN Trial Results Presentation